Regulus Therapeutics Inc. - Filer Information

Symbol
RGLS on Nasdaq
Entity
Company
CIK
0001505512
EIN
264738379
Business address
4224 Campus Point Court, Suite 210, 92121 San Diego, CA
Phone
858-202-6300
State of incorporation
DE
Fiscal year end
December 31
Category
Non-accelerated filer
Smaller reporting company
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company